The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Hematopoietic stem cell transplantation in Waldenström's macroglobulinemia

During the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the Lymphoma Hub spoke to Charalampia Kyriakou, University College London, London, UK. We asked her to speak about the role hematopoietic stem cell transplantation in Waldenström's macroglobulinemia (WM).

Hematopoietic stem cell transplantation in Waldenström's macroglobulinemia

WM is a rare indolent lymphoma and is considered an orphan disease. In this video, Charalampia Kyriakou talks about which patients are suitable for transplant, the impact of the timing of transplantation, along with the introduction of novel therapies in patients with WM.

Share: